M. Proeschel

Potentiation of the classic ovine corticotrophin releasing hormone stimulation test by the combined administration of small doses of lysine vasopressin

X. Bertagna, J. Luton, M. Raux-Demay, 1993, Clinical endocrinology.

High plasma proopiomelanocortin in aggressive adrenocorticotropin-secreting tumors.

X. Bertagna, J. Luton, M. Raux-Demay, 1996, The Journal of clinical endocrinology and metabolism.

CHARACTERIZATION OF HUMAN CORTICOTROPHIN‐RELEASING HORMONE AND PRO‐OPIOMELANOCORTIN‐RELATED PEPTIDES IN A THYMIC CARCINOID TUMOUR RESPONSIBLE FOR CUSHING'S SYNDROME

X. Bertagna, J. Luton, M. R. Demay, 1988, Clinical endocrinology.

Comparative assessment of ACTH and lipotropin plasma levels in the diagnosis and follow-up of patients with Cushing's syndrome: a study of 210 cases.

X. Bertagna, J. Luton, F. Girard, 1989, The American journal of medicine.

Pro-opiomelanocortin peptides in the human hypothalamus: Comparative study between normal subjects and parkinson patients

Y. Agid, H. Vaudry, X. Bertagna, 1985, Neuroscience Letters.

Preparation and evaluation of ACTH antibodies.

M. Binoux, F. Girard, M. Proeschel, 1974, Acta endocrinologica.

High plasma proopiomelanocortin in aggressive adrenocorticotropin-secreting tumors.

X. Bertagna, J. Luton, M. Raux-Demay, 1996, The Journal of clinical endocrinology and metabolism.

Simultaneous evaluation of the catecholamine pathway and three opioid peptide producing systems in human pheochromocytomas

J. Thibault, X. Bertagna, J. Luton, 1984, Neuropeptides.

Genetic factors regulate processes related to anxiety in mice

J. Launay, D. Bondoux, F. Girard, 1997, Brain Research.